Riskpilot← Back to searchSign inGet full accessKjersti Iwar Fysioterapi AB
ABActiveOrg 5569670317Bryggavägen 8Physiotherapy activities · NACE 8695Est. 20141 employees
Revenue 2024
SEK 1,3M
+17% vs 2023
EBITDA margin
17.9%
+395% vs 2023
Equity ratio
79.1%
Financial strength
Net profit 2024
SEK 181K
+353% vs 2023
| Revenue | SEK 1,3M | +17% |
| EBITDA | SEK 228K | +395% |
| Net profit | SEK 181K | +353% |
| Total assets | SEK 553K | +56% |
| Equity | SEK 438K | +70% |
| Employees | 1 | — |
Legal name
Kjersti Iwar Fysioterapi AB
Org number
5569670317
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
1 april 2014
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva fysioterapi, konsultverksamhet inom sjukvård, träning och hälsa samt därmed förenlig verksamhet.
Address
Bryggavägen 8
Email
kjersti@iwar.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | — | 0 | 262 | 1 089 | 1 270 |
| Staff expenses | — | — | −124 | −778 | −796 |
| EBITDA | 0 | −11 | 10 | 46 | 228 |
| Depreciation & amort. | — | −0 | — | — | — |
| EBIT | 0 | −11 | 10 | 46 | 228 |
| Net financials | — | — | −1 | 3 | 0 |
| Profit before tax | 0 | −11 | 9 | 49 | 228 |
| Tax | — | −0 | — | −9 | −47 |
| Net profit | — | −11 | 9 | 40 | 181 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | — | 312 | 251 | 356 | 553 |
| Equity | — | 208 | 217 | 257 | 438 |
| Long-term debt | — | 0 | — | — | — |
| Short-term debt | — | 104 | 34 | 99 | 116 |
| Total debt | — | 104 | 34 | 99 | 116 |
EBITDA margin
17.9%
This company
15.8%
Market median
+13% vs market
20202024
Equity ratio
79.1%
This company
38.2%
Market median
+107% vs market
20202024
Return on equity
41.3%
This company
18.4%
Market median
+124% vs market
20202024
Net profit margin
14.2%
This company
8.1%
Market median
+75% vs market
20202024
Asset turnover
2.30×
This company
1.12×
Market median
+105% vs market
20202024
Debt / equity
0.26×
This company
0.62×
Market median
+58% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KO Chief Executive Officer | Chief Executive Officer | 2020 |
| Former (1) | ||
KA Authorized Recipient of Service | Authorized Recipient of Service | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Kjersti Iwar Fysioterapi AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristina Annie Margareta Iwar | Authorized Recipient of Service | 0 companies |
| Kjersti Olsen Iwar | Chief Executive Officer | 0 companies |
| Eric Johan Iwar | Deputy Board Member | 0 companies |